NL-OMON34294已完成不适用
An open-label, single-arm study to determine the excretion balance and metabolic disposition of [14C]GW642444 administered as a single dose of an oral solution to healthy male volunteers - [14C]-GW642444 ADME study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1.Healthy male aged between 30 and 55 years inclusive, at the time of signing the informed consent.
- •2.Body Mass Index (BMI) within the range 18.5-29.0 kg/m2.
- •3.Subjects who are current non-smokers, who have not used any tobacco products in the 12 month period preceding the screening visit, and have a pack history of * 5 pack years.
排除标准
- •1.Suffering from: hepatitis B, cancer or HIV/AIDS. In case of participation in another drug study within 60 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study.
研究者
相似试验
进行中（未招募）
不适用
A study in patients with metastatic prostate cancer to assess how the drug Eligard®, affects certain markers in blood and urine, which are indicators for the disease.Patients with metastatic prostate cancer whom androgen deprivation therapy (ADT) is indicatedMedDRA version: 17.0Level: LLTClassification code 10007113Term: Cancer of prostateSystem Organ Class: 100000004864EUCTR2012-000101-69-NLAstellas Pharma Europe Ltd. (APEL)
已完成
4 期
An exploratory, open label, single-arm study to evaluate the effect of Eligard® 6-month on biomarkers of disease in patients with metastatic prostate cancerMetastatic prostate cancermalignity of the prostate with metastases1002747610036958NL-OMON40179Astellas Pharma B.V.50
已完成
3 期
To Evaluate the Effect of Padabhyanga with Ksheerabala Taila in Insomnia among Breast Cancer SurvivorsCTRI/2021/12/038531Dr Veena22
尚未招募
3 期
To Evaluate the Effect of Pratimarsa Nasya with Ksheerabala Thaila 101 in Digital Eye Strain among College Students.CTRI/2022/07/044496Dr Reshma Mohan
招募中
Unknown
An open-label, single-arm study to investigate the efficacy of Favipiravir on Lassa Fever for Post Exposure Prophylaxisassa feverJPRN-jRCTs031230118Morioka Shinichiro5